Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination (Q39473407)

12 September 2017

title

Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination (English)

1 reference

12 September 2017

Mycobacterium bovis

1 reference

5

1 reference

12 September 2017

Camille Locht

4

0 references

author name string

Steven G Smith

series ordinal

1

1 reference

12 September 2017

Sophie Lecher

series ordinal

2

1 reference

12 September 2017

Rose Blitz

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 August 2012

1 reference

European Journal of Immunology

12 September 2017

published in

1 reference

12 September 2017

volume

42

1 reference

12 September 2017

issue

9

1 reference

12 September 2017

page(s)

2511-2522

1 reference

Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Identification of a heparin-binding hemagglutinin present in mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Neonatal vaccination with Mycobacterium bovis BCG: potential effects as a priming agent shown in a heterologous prime-boost immunization protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Recombinant HBHA boosting effect on BCG-induced immunity against Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Complex cytokine profiles induced by BCG vaccination in UK infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Transcriptional profiling of innate and adaptive human immune responses to mycobacteria in the tuberculin skin test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Disseminated tuberculosis in interferon gamma gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

7 January 2021

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

7 January 2021

Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

7 January 2021

Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

7 January 2021

Human deficiencies in type-1 cytokine receptors reveal the essential role of type-1 cytokines in immunity to intracellular bacteria.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142297

7 January 2021

Identifiers

DOI

10.1002/EJI.201142297

1 reference

12 September 2017

1 reference